Back to results
US 5,470,833 AGranted
Endothelin antagonistic peptide derivatives
AssigneeBanyu Pharmaceutical Co., Ltd.
InventorsKiyofumi Ishikawa, Takehiro Fukami, Takashi Hayama, Kenji Niiyama, Toshio Nagase, Toshiaki Mase, Kagari Fujita, Masaki Ihara, Fumihiko Ikemoto, Mitsuo Yano
Life of this patent
Estimating the term…
Abstract
Peptides having the formula: ##STR1## inhibit the binding of endothelin to its receptor and are useful in treating diseases associated with excess production or secretion of endothelin.
Claims55
A peptide of the formula:
- ##STR180## wherein A.sup.1 is a group of the formula R.sup.11 --CO--, wherein R.sup.11 is a lower alkyl group, a cycloalkyl group, a cycloalkyl lower alkyl group, a group of the formula Ar.sup.1 --(CH.sub.2).sub.p -- wherein Ar.sup.1 is a phenyl group, a furyl group or a thienyl group, and p is 0, 1 or 2, a 1,3-dithiol-2-ylidenemethyl group, or a 1,3-dithiol-2-ylidene(lower alkoxycarbonyl)methyl group,
- B is an oxygen atom or a group of the formula --NR.sup.2 -- wherein R.sup.2 is a hydrogen atom or a methyl group,
- R.sup.3 is a lower alkyl group having 3 to 5 carbon atoms;
- R.sup.4 is a hydrogen atom or a methyl group;
- R.sup.5 is a 3-indolylmethyl group, a (2,3-dihydro-2-oxo-3-indolyl)methyl group, a 3-indolylmethyl group wherein the indole ring is substituted at the 1-position by a group of the formula R.sup.51 --CO--(CH.sub.2).sub.s -- wherein R.sup.51 is a hydrogen atom, a lower alkyl group, a hydroxyl group, a lower alkoxy group, a benzyloxy group, an amino group or a mono lower alkylamino group, s is an integer of from 0 to 6, provided that when s=0, R.sup.51 is other than a hydroxyl group, or a group of the formula (R.sup.52 O).sub.2 P(.dbd.O)--(CH.sub.2).sub.t -- wherein R.sup.52 is a hydrogen atom, a lower alkyl group or a benzyl group, and t is an integer of from 0 to 6, a benzyl group wherein an optional hydrogen atom on the benzene ring may be replaced by a group of the formula R.sup.53 O--CO--(CH.sub.2).sub.u -- wherein R.sup.53 is a hydrogen atom or a lower alkyl group, and u is an integer of from 0 to 6, a benzyl group wherein one or two optional hydrogen atoms on the benzene ring are replaced by a hydroxyl group(s), or two optional hydrogen atoms on the benzene ring are replaced by a hydroxyl group and a sulfo group, a 3-benzothienylmethyl group, a (1-oxo-3-benzothienyl)methyl group, or a (1,1-dioxo-3-benzothienyl)methyl group;
- X.sup.2 is an oxygen atom or a sulfur atom;
- A.sup.2 is selected from the group consisting of the following formulas (V), (VII, (VII) and (VIII):
- ##STR181## wherein Y is (a) a group of the formula --CO.sub.2 R.sup.91 wherein R.sup.91 is a hydrogen atom, a lower alkyl group or a benzyl group, or
- (b) a group of the formula --CONR.sup.92 R.sup.93 wherein R.sup.92 is a hydrogen atom, a lower alkyl group, a lower alkylsulfonyl group, a phenylsulphonyl group wherein one to five optional hydrogen atoms on the benzene ring may independently be replaced by a lower alkyl group or a halogen atom, or a carboxymethyl group, and R.sup.9 is a hydrogen atom or a lower alkyl group, v is 3, 4 or 5, R.sup.63 is a hydrogen atom, a lower alkyl group, a carboxy lower alkyl group, a group of the formula Ar.sup.4 --(CH.sub.2).sub.w -- wherein Ar.sup.4 is a phenyl group, a furyl group or a thienyl group, and w is 1 or 2, Z is CH or N, and x is 1, 2 or 3;
- or a pharmaceutically acceptable salt thereof.
7 more elements
A peptide of the formula:
- ##STR185## wherein A.sup.1 is a group of the formula R.sup.12 O--CO-- wherein R.sup.12 is a lower alkyl group, a cycloalkyl group, a cycloalkyl lower alkyl group or a phenyl group,
- B is an oxygen atom or a group of the formula --NR.sup.2 -- wherein R.sup.2 is a hydrogen atom or a methyl group;
- R.sup.3 is a lower alkyl group having 3 to 5 carbon atoms;
- R.sup.4 is a hydrogen atom or a methyl group;
- R.sup.5 is a 3-indolylmethyl group, a (2,3-dihydro-2-oxo-3-indolyl)methyl group, a 3-indolylmethyl group wherein the indole ring is substituted at the 1-position by a group of the formula R.sup.51 --CO--(CH.sub.2).sub.s -- wherein R.sup.51 is a hydrogen atom, a lower alkyl group, a hydroxyl group, a lower alkoxy group, a benzyloxy group, an amino group or a mono lower alkylamino group, s is an integer of from 0 to 6, provided that when s=0, R.sup.51 is other than a hydroxyl group, or a group of the formula (R.sup.52 O).sub.2 P(.dbd.O)--(CH.sub.2).sub.t -- wherein R.sup.52 is a hydrogen atom, a lower alkyl group or a benzyl group, and t is an integer of from 0 to 6, a benzyl group wherein an optional hydrogen atom on the benzene ring may be replaced by a group of the formula R.sup.53 O--CO--(CH.sub.2).sub.u -- wherein R.sup.53 is a hydrogen atom or a lower alkyl group, and u is an integer of from 0 to 6, a benzyl group wherein one or two optional hydrogen atoms on the benzene ring are replaced by a hydroxyl, group(s), or two optional hydrogen atoms on the benzene ring are replaced by a hydroxyl group and a sulfo group, a 3-benzothienylmethyl group, a (1-oxo-3-benzothienyl)methyl group, or a (1,1-dioxo-3-benzothienyl)methyl group;
- X.sup.2 is an oxygen atom or a sulfur atom;
- A.sup.2 is selected from the group consisting of the following formulas (V), (VI), (VII) and (VIII):
- ##STR186## wherein Y is (a) a group of the formula --CO.sub.2 R.sup.91 wherein R.sup.91 is a hydrogen atom, a lower alkyl group or a benzyl group, or
- (b) a group of the formula --CONR.sup.92 R.sup.93 wherein R.sup.92 is a hydrogen atom, a lower alkyl group, a lower alkylsulfonyl group, a phenylsulphonyl group wherein one to five optional hydrogen atoms on the benzene ring may independently be replaced by a lower alkyl group or a halogen atom, or a carboxymethyl group, and R.sup.93 is a hydrogen atom or a lower alkyl group, v is 3, 4 or 5, R.sup.63 is a hydrogen atom, a lower alkyl group, a carboxy lower alkyl group, a group of the formula Ar.sup.4 --(CH.sub.2).sub.w -- wherein Ar.sup.4 is a phenyl group, a furyl group or a thienyl group, and w is 1 or 2, Z is CH or N, and x is 1, 2 or 3;
- or a pharmaceutically acceptable salt thereof.
7 more elements
A peptide of the formula:
- ##STR190## wherein A.sup.1 is a group of the formula R.sup.13 R.sup.14 N--C(.dbd.X.sup.1)-- wherein
- X.sup.1 is an oxygen atom or a sulfur atom,
- R.sup.13 is a lower alkyl group which may be substituted by a lower alkoxycarbonyl group, a cycloalkyl group, a lower alkynyl group, a 1-adamantyl group, a pyrrolidino group, a piperidino group, a perhydroazepin-1-yl group, a perhydroazocin-1-yl group, a perhydroazonin-1-yl group, or a group of the formula Ar.sup.2 --(CH.sub.2).sub.q -- wherein Ar.sup.2 is a phenyl group wherein one or two optional hydrogen atoms on the benzene ring may independently be replaced by a halogen atom, a lower alkyl group or a lower alkoxy group, a furyl group, or a thienyl group, and q is 0,1 or 2,
- R.sup.14 is a hydrogen atom, a lower alkyl group which may be substituted by a hydroxyl group, a cycloalkyl group, or a group of the formula Ar.sup.3 --(CH.sub.2).sub.r -- wherein Ar.sup.3 is a phenyl group, a furyl group or a thienyl group, and r is 1 or 2,
- B is an oxygen atom or a group of the formula --NR.sup.2 -- wherein R.sup.2 is a hydrogen atom or a methyl group;
- R.sup.3 is a lower alkyl group having 3 to 5 carbon atoms;
- R.sup.4 is a hydrogen atom or a methyl group;
- R.sup.5 is a 3-indolylmethyl group, a (2,3-dihydro-2-oxo-3-indolyl)methyl group, a 3-indolylmethyl group wherein the indole ring is substituted at the 1-position by a group of the formula R.sup.51 --CO--(CH.sub.2).sub.s -- wherein R.sup.51 is a hydrogen atom, a lower alkyl group, a hydroxyl group, a lower alkoxy group, a benzyloxy group, an amino group or a mono lower alkylamino group, s is an integer of from 0 to 6, provided that when s=0, R.sup.51 is other than a hydroxyl group, or a group of the formula (R.sup.52 O).sub.2 P(.dbd.O)--(CH.sub.2).sub.t -- wherein R.sup.52 is a hydrogen atom, a lower alkyl group or a benzyl group, and t is an integer of from 0 to 6, a benzyl group wherein an optional hydrogen atom on the benzene ring may be replaced by a group of the formula R.sup.53 O--CO--(CH.sub.2).sub.u -- wherein R.sup.53 is a hydrogen atom or a lower alkyl group, and u is an integer of from 0 to 6, a benzyl group wherein one or two optional hydrogen atoms on the benzene ring are replaced by a hydroxyl group(s), or two optional hydrogen atoms on the benzene ring are replaced by a hydroxyl group and a sulfo group, a 3-benzothienylmethyl group, a (1-oxo-3-benzothienyl)methyl group, or a (1,1-dioxo-3-benzothienyl)methyl group;
- X.sup.2 is an oxygen atom or a sulfur atom;
- A.sup.2 is selected from the group consisting of the following formulas (V), (VI), (VII) and (VIII):
- ##STR191## wherein Y is (a) a group of the formula --CO.sub.2 R.sup.91 wherein R.sup.91 is a hydrogen atom, a lower alkyl group or a benzyl group, or
- (b) a group of the formula --CONR.sup.92 R.sup.93 wherein R.sup.92 is a hydrogen atom, a lower alkyl group, a lower alkylsulfonyl group, a phenylsulphonyl group wherein one to five optional hydrogen atoms on the benzene ring may independently be replaced by a lower alkyl group or a halogen atom, or a carboxymethyl group, and R.sup.93 is a hydrogen atom or a lower alkyl group, v is 3, 4 or 5, R.sup.63 is a hydrogen atom, a lower alkyl group, a carboxy lower alkyl group, a group of the formula Ar.sup.4 --(CH.sub.2).sub.w -- wherein Ar.sup.4 is a phenyl group, a furyl group or a thienyl group, and w is 1 or 2, Z is CH or N, and x is 1, 2 or 3;
- or a pharmaceutically acceptable salt thereof.
10 more elements
A peptide of the formula:
- ##STR195## wherein A.sup.1 is a group of the formula R.sup.13 R.sup.14 N--C(.dbd.X.sup.1)-- wherein
- X.sup.1 is an oxygen atom or a sulfur atom,
- R.sup.13 and R.sup.14 form, together with the adjacent nitrogen atom, a 5- to 9-membered nitrogen-containing saturated heterocyclic ring having 4 to 8 carbon atoms, wherein among methylene groups forming the ring, one optional methylene group not adjacent to the above nitrogen atom may be replaced by an oxy group, a thio group or a group of the formula --NR.sup.15 -- wherein R.sup.15 is a lower alkyl group, and one to four optional hydrogen atoms on the carbon atoms of the heterocyclic ring may independently be replaced by a hydroxyl group or a lower alkyl group which may be substituted by a hydroxyl group, and further two adjacent carbon atoms in the heterocyclic ring may form a double bond or a benzo-fuzed ring,
- B is an oxygen atom or a group of the formula --NR.sup.2 -- wherein R.sup.2 is a hydrogen atom or a methyl group;
- R.sup.3 is a lower alkyl group having 3 to 5 carbon atoms;
- R.sup.4 is a hydrogen atom or a methyl group;
- R.sup.5 is a 3-indolylmethyl group, a (2,3-dihydro-2-oxo-3-indolyl)methyl group, a 3-indolylmethyl group wherein the indole ring is substituted at the 1-position by a group of the formula R.sup.51 --CO--(CH.sub.2).sub.s -- wherein R.sup.51 is a hydrogen atom, a lower alkyl group, a hydroxyl group, a lower alkoxy group, a benzyloxy group, an amino group or a mono lower alkylamino group, s is an integer of from 0 to 6, provided that when s=0, R.sup.51 is other than a hydroxyl group, or a group of the formula (R.sup.52 O).sub.2 P(.dbd.O)--(CH.sub.2).sub.t -- wherein R.sup.52 is a hydrogen atom, a lower alkyl group or a benzyl group, and t is an integer of from 0 to 6, a benzyl group wherein an optional hydrogen atom on the benzene ring may be replaced by a group of the formula R.sup.53 O--CO--(CH.sub.2).sub.u -- wherein R.sup.53 is a hydrogen atom or a lower alkyl group, and u is an integer of from 0 to 6, a benzyl group wherein one or two optional hydrogen atoms on the benzene ring are replaced by a hydroxyl group(s), or two optional hydrogen atoms on the benzene ring are replaced by a hydroxyl group and a sulfo group, a 3-benzothienylmethyl group, a (1-oxo-3-benzothienyl)methyl group, or a (1,1-dioxo-3-benzothienyl)methyl group;
- X.sup.2 is an oxygen atom or a sulfur atom;
- A.sup.2 is selected from the group consisting of the following formulas (V), (VI), (VII) and (VIII):
- ##STR196## wherein Y is (a) a group of the formula --CO.sub.2 R.sup.91 wherein R.sup.91 is a hydrogen atom, a lower alkyl group or a benzyl group, or
- (b) a group of the formula --CONR.sup.92 R.sup.93 wherein R.sup.92 is a hydrogen atom, a lower alkyl group, a lower alkylsulfonyl group, a phenylsulphonyl group wherein one to five optional hydrogen atoms on the benzene ring may independently be replaced by a lower alkyl group or a halogen atom, or a carboxymethyl group, and R.sup.93 is a hydrogen atom or a lower alkyl group, v is 3, 4 or 5, R.sup.63 is a hydrogen atom, a lower alkyl group, a carboxy lower alkyl group, a group of the formula Ar.sup.4 --(CH.sub.2).sub.w -- wherein Ar.sup.4 is a phenyl group, a furyl group or a thienyl group, and w is 1 or 2, Z is CH or N, and x is 1, 2 or 3;
- or a pharmaceutically acceptable salt thereof.
9 more elements
A peptide of the formula:
- ##STR200## wherein A.sup.1 is a group of the formula R.sup.13 R.sup.14 N--C(.dbd.X.sup.1)-- wherein
- X.sup.1 is an oxygen atom
- R.sup.13 and R.sup.14 together with B represents a group of the following formula (II):
- ##STR201## wherein R.sup.16 is a hydrogen atom, a lower alkyl group or a cycloalkyl group, and each of R.sup.17 and R.sup.18, which are independent from each other, is a hydrogen atom or a lower alkyl group;
- R.sup.3 is a lower alkyl group having 3 to 5 carbon atoms;
- R.sup.4 is a hydrogen atom or a methyl group;
- R.sup.5 is a 3-indolylmethyl group, a (2,3-dihydro-2-oxo-3-indolyl)methyl group, a 3-indolylmethyl group wherein the indole ring is substituted at the 1-position by a group of the formula R.sup.51 --CO--(CH.sub.2).sub.s -- wherein R.sup.51 is a hydrogen atom, a lower alkyl group, a hydroxyl group, a lower alkoxy group, a benzyloxy group, an amino group or a mono lower alkylamino group, s is an integer of from 0 to 6, provided that when s=0, R.sup.51 is other than a hydroxyl group, or a group of the formula (R.sup.52 O).sub.2 P(.dbd.O)--(CH.sub.2).sub.t -- wherein R.sup.52 is a hydrogen atom, a lower alkyl group or a benzyl group, and t is an integer of from 0 to 6, a benzyl group wherein an optional hydrogen atom on the benzene ring may be replaced by a group of the formula R.sup.53 O--CO--(CH.sub.2).sub.u -- wherein R.sup.53 is a hydrogen atom or a lower alkyl group, and u is an integer of from 0 to 6, a benzyl group wherein one or two optional hydrogen atoms on the benzene ring are replaced by a hydroxyl group(s), or two optional hydrogen atoms on the benzene ring are replaced by a hydroxyl group and a sulfo group, a 3-benzothienylmethyl group, a (1-oxo-3-benzothienyl)methyl group, or a (1,1-dioxo-3-benzothienyl ) methyl group;
- X.sup.2 is an oxygen atom or a sulfur atom;
- A.sup.2 is selected from the group consisting of the following formulas (V), (VI), (VII) and (VIII):
- ##STR202## wherein Y is (a) a group of the formula --CO.sub.2 R.sup.91 wherein R.sup.91 is a hydrogen atom, a lower alkyl group or a benzyl group, or
- (b) a group of the formula --CONR.sup.92 R.sup.93 wherein R.sup.92 is a hydrogen atom, a lower alkyl group, a lower alkylsulfonyl group, a phenylsulphonyl group wherein one to five optional hydrogen atoms on the benzene ring may independently be replaced by a lower alkyl group or a halogen atom, or a carboxymethyl group, and R.sup.93 is a hydrogen atom or a lower alkyl group, v is 3, 4 or 5, R.sup.63 is a hydrogen atom, a lower alkyl group, a carboxy lower alkyl group, a group of the formula Ar.sup.4 --(CH.sub.2).sub.w -- wherein Ar.sup.4 is a phenyl group, a furyl group or a thienyl group, and w is 1 or 2, Z is CH or N, and x is 1, 2 or 3;
- or a pharmaceutically acceptable salt thereof.
9 more elements
Dependencies are inferred from the claim text.